Orion Oyj
Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.
ORNAV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009014377 (+1 more)
- LEI:
- 74370029VAHCXDR7B745
- Country:
- Finland
- Address:
- Orionintie 1, FI-02200 ESPOO
- Website:
- https://www.orion.fi/en/
- Sector:
- Manufacturing
Description
Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2010-11-01 14:46 |
Orion Oyj:n nimitysvaliokunnan kokoonpano
|
Finnish | HTML • 1.4 KB | ||
| 2010-10-20 14:08 |
Euroopan lääkevirasto aloittanut Orionin deksmedetomidiinia koskevan myyntilupa…
|
Finnish | HTML • 1.9 KB | ||
| 2010-10-20 14:08 |
European Medicines Agency has initiated the review of Orion´s dexmedetomidine m…
|
English | HTML • 1.3 KB | ||
| 2010-10-15 15:46 |
Arvopaperimarkkinalain 2 luvun 9 §:n mukainen liputusilmoitus
|
Finnish | HTML • 2.6 KB | ||
| 2010-10-15 15:46 |
Disclosure Under Chapter 2 Section 9
|
English | HTML • 2.6 KB | ||
| 2010-10-11 09:31 |
Orion invites analysts and media to Q3 news conference on Tuesday 26 October 20…
|
English | HTML • 2.8 KB | ||
| 2010-10-11 09:31 |
Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 2…
|
Finnish | HTML • 2.8 KB | ||
| 2010-09-24 11:05 |
Muutos Orion-konsernin johtoryhmässä 1.1.2011 alkaen
|
Finnish | HTML • 2.3 KB | ||
| 2010-09-24 11:05 |
Change in Orion Group Executive Management Board as of 1 Jan 2011
|
English | HTML • 2.5 KB | ||
| 2010-09-01 09:20 |
Orion: Muutos omien osakkeiden omistuksessa
|
Finnish | HTML • 912 bytes | ||
| 2010-09-01 09:20 |
Orion: Change in the holding of own shares
|
English | HTML • 1006 bytes | ||
| 2010-08-20 17:50 |
Orion comments on today's FDA release on safety review of Stalevo®
|
English | HTML • 3.4 KB | ||
| 2010-08-20 17:50 |
Orion kommentoi FDA:n tämänpäiväistä tiedotetta Stalevo®-lääkkeestä
|
Finnish | HTML • 3.7 KB | ||
| 2010-08-18 16:30 |
SHARE ACQUISITIONS 18/08/2010
|
Finnish | HTML • 895 bytes | ||
| 2010-08-18 16:30 |
SHARE ACQUISITIONS 18/08/2010
|
English | HTML • 866 bytes |
Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orion Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orion Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
